Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Arcus Biosciences, Inc. | 224,024 | reported | 23 Jan 2026 | tx 73+2,646,047−682,614 |
| Syndax Pharmaceuticals Inc | 114,000 | reported | 04 Feb 2026 | tx 9+197,000 |
| Zura Bio Ltd | 51,000 | reported | 21 May 2025 | tx 3+175,652 |
| Sagimet Biosciences Inc. | 27,268 | reported | 09 Jun 2025 | tx 2+141,163 |
| ARENA PHARMACEUTICALS INC | 3,067 | reported | 11 Mar 2022 | tx 18+258,419−55,919 |
| MEDIVATION, INC. | 0 | reported | 28 Sept 2016 | tx 5+149,856−187,319 |
| Surrozen, Inc./DE | 0 | reported | 11 Aug 2021 | tx 2+30,000−30,000 |
| MPM ACQUISITION CORP | 0 | reported | 15 Aug 2022 | tx 2+30,000−30,000 |
| Audentes Therapeutics, Inc. | 0 | reported | 15 Jan 2020 | tx 8+53,200−53,200 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Feb 2026 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 24,000 | 0.00 USD | |
| 23 Jan 2026 | GRANT_AWARD | Arcus Biosciences, Inc. | 31,000 | 0.00 USD | |
| 23 Jan 2026 | GRANT_AWARD | Arcus Biosciences, Inc. | 126,000 | 0.00 USD | deriv |
| 17 Dec 2025 | SALE | Arcus Biosciences, Inc. | 9,983 | 22.16 USD | |
| 16 Dec 2025 | SALE | Arcus Biosciences, Inc. | 11,225 | 21.88 USD | |
| 07 Nov 2025 | SALE | Arcus Biosciences, Inc. | 50,291 | 18.97 USD | |
| 07 Nov 2025 | EXERCISE | Arcus Biosciences, Inc. | 50,291 | 1.23 USD | |
| 07 Nov 2025 | EXERCISE | Arcus Biosciences, Inc. | 50,291 | 1.23 USD | deriv |
| 08 Oct 2025 | EXERCISE | Arcus Biosciences, Inc. | 37,792 | 1.23 USD | |
| 08 Oct 2025 | SALE | Arcus Biosciences, Inc. | 37,792 | 15.05 USD | |
| 06 Oct 2025 | SALE | Arcus Biosciences, Inc. | 12,500 | 14.54 USD | |
| 06 Oct 2025 | EXERCISE | Arcus Biosciences, Inc. | 12,500 | 1.23 USD | |
| 06 Oct 2025 | EXERCISE | Arcus Biosciences, Inc. | 12,500 | 0.00 USD | deriv |
| 08 Oct 2025 | EXERCISE | Arcus Biosciences, Inc. | 37,792 | 0.00 USD | deriv |
| 09 Jun 2025 | GRANT_AWARD | Sagimet Biosciences Inc. | 27,268 | 0.00 USD | deriv |
| 21 May 2025 | GRANT_AWARD | Zura Bio Ltd | 51,000 | 0.00 USD | deriv |
| 05 Feb 2025 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 25,000 | 0.00 USD | |
| 23 Jan 2025 | GRANT_AWARD | Arcus Biosciences, Inc. | 50,000 | 0.00 USD | |
| 23 Jan 2025 | GRANT_AWARD | Arcus Biosciences, Inc. | 200,000 | 0.00 USD | deriv |
| 15 Dec 2024 | TAX_WITHHOLDING | Arcus Biosciences, Inc. | 27,501 | 16.08 USD | |
| 09 Dec 2024 | GRANT_AWARD | Zura Bio Ltd | 117,000 | 0.00 USD | deriv |
| 15 Sept 2024 | TAX_WITHHOLDING | Arcus Biosciences, Inc. | 12,670 | 17.95 USD | |
| 01 Aug 2024 | GRANT_AWARD | Sagimet Biosciences Inc. | 113,895 | 0.00 USD | deriv |
| 15 Jun 2024 | TAX_WITHHOLDING | Arcus Biosciences, Inc. | 12,670 | 16.97 USD | |
| 27 Mar 2024 | SALE | Arcus Biosciences, Inc. | 11,551 | 17.55 USD |